Related Experiment Video
Updated: Aug 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Establishing community pharmacy-based anticoagulation education and monitoring programs
C H Knowlton1, O V Thomas, A Williamson
1Hospice Pharmacia, Philadelphia, PA 19103, USA.
Objective:
To determine the process for establishing community pharmacy-based anticoagulation education and monitoring programs using fingerstick capillary whole blood testing.
Design:
Pilot community-based intervention study using convenience sample of patients.
Setting:
Three community pharmacies with pre-established health education centers and laboratories certified for moderate complexity.
Participants:
26 patients were referred to the clinics by 2 primary care physicians for each pharmacy, most with a diagnosis of atrial fibrillation.
Intervention:
Patient assessment, including adherence to prescribed regimens; changes in medication use, including prescription and nonprescription medications, vitamins, health foods, and nutrition supplements; changes in diet and ethanol consumption; assessment of adverse experiences; and needed changes in warfarin dosage.
Main Outcome Measures:
Percentage of international normalized ratio (INR) values within therapeutic range, major bleeding events, and thrombotic events.
Results:
A total of 21 patient charts were available for analysis. More than 80% of patients had INR values within their targeted range (+/- 0.2) 60% or more of the time, comparable with values reported for anticoagulation clinics. Of the 235 INR values obtained during the study, 75% were within the individualized targeted therapeutic range (e.g., 2 to 3 +/- 0.2). One patient experienced a major bleeding event related to an underlying cancer. None of the patients experienced a thrombotic event.
Conclusion:
Community pharmacies can effectively implement an anticoagulation education and monitoring program.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

